Copyright
©The Author(s) 2015.
World J Diabetes. Jun 10, 2015; 6(5): 693-706
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.693
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.693
Ref. | Year | R-D | UR-D | Total study patients | Location | Diabetes diagnosed by | Unrecognised diabetes diagnosed by |
Umpierrez et al[14] | 2002 | 495 (26%) | 2231 (12%) | 1886 | Atlanta, United States | Admission history | Fasting blood glucose ≥ 7 mmol/LRandom blood glucose ≥ 11.1 mmol/L × 2 |
Wallymahmed et al[15] | 2005 | 126 (11%) | 131 (1%) | 1129 | Liverpool, United Kingdom | Admission historyHospital records | Random blood glucose ≥ 11.1 mmol/L |
Wexler et al[17] | 2008 | 136 (19%) | 33 (5%) | 695 | Boston, United States | Admission historyHospital records | HbA1c > 6.5 |
Mazurek et al[18] | 2010 | 342 (35%) | 152 (16%) | 971 | New York, United States | Admission historyHospital recordsMedication review | HbA1c ≥ 6.5 |
Feldman-Billard et al[16] | 2013 | 355 (17%) | 1561 (7%) | 2141 | Multicentre (France) | Admission history | Fasting blood glucose ≥ 7 mmol/L |
- Citation: Kar P, Jones KL, Horowitz M, Deane AM. Management of critically ill patients with type 2 diabetes: The need for personalised therapy. World J Diabetes 2015; 6(5): 693-706
- URL: https://www.wjgnet.com/1948-9358/full/v6/i5/693.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i5.693